ConductScience.org, home

Paper447033

Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis.

Neal EA and 3 others. Gastroenterology, 1979. Cited by 119 papers, by iCite.

Cite this record

ConductScience Library. Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis. Papers, record 447033. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/447033

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis.
PubMed
Journal
Gastroenterology
PubMed
Year
1979
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
119
iCite
Relative citation ratio, by iCite
6.79
iCite
Revised in PubMed
2013-11-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Neal EAE A
2Meffin PJP J
3Gregory PBP B
4Blaschke TFT F

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LiverMajor topic
Liver CirrhosisMajor topic
MeperidineMajor topic
PentazocineMajor topic
SalicylamidesMajor topic
Adult
Biological Availability
Half-Life
Humans
Liver Circulation
Liver Function Tests
Middle Aged

Source PubMed

Download CSV of topics

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.

PMIDTitleJournalYearIn PapersSource
38399287Simultaneously Predicting the Pharmacokinetics of CES1-Metabolized Drugs and Their Metabolites Using Physiologically Based Pharmacokinetic Model in Cirrhosis Subjects.Pharmaceutics2024https://conductscience.org/library/papers/38399287PubMed
27939376The Promises of Quantitative Proteomics in Precision Medicine.J Pharm Sci2017https://conductscience.org/library/papers/27939376PubMed
22867045Analgesics in patients with hepatic impairment: pharmacology and clinical implications.Drugs2012https://conductscience.org/library/papers/22867045PubMed
22346246Update of endoscopy in liver disease: more than just treating varices.World J Gastroenterol2012https://conductscience.org/library/papers/22346246PubMed
18762933Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.Eur J Clin Pharmacol2008https://conductscience.org/library/papers/18762933PubMed
15924505Dose adjustment in patients with liver disease.Drug Saf2005https://conductscience.org/library/papers/15924505PubMed
10451781Pharmacokinetics of opioids in liver disease.Clin Pharmacokinet1999https://conductscience.org/library/papers/10451781PubMed
9820880Effect of hepatic insufficiency on pharmacokinetics and drug dosing.Pharm World Sci1998https://conductscience.org/library/papers/9820880PubMed
9638390Pain treatment in multimorbid patients, the older population and other high-risk groups. The clinical challenge of reducing toxicity.Drug Saf1998https://conductscience.org/library/papers/9638390PubMed
9258630Drug administration in chronic liver disease.Drug Saf1997https://conductscience.org/library/papers/9258630PubMed
8261714Individual variation in first-pass metabolism.Clin Pharmacokinet1993https://conductscience.org/library/papers/8261714PubMed
7333059Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.Clin Pharmacokinet1981https://conductscience.org/library/papers/7333059PubMed
7248141Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7248141PubMed
7213505Pethidine clearance during continuous intravenous infusions in postoperative patients.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7213505PubMed
7094988Comparative disposition of pethidine and norpethidine in old and young patients.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7094988PubMed
6861871Steady-state kinetics and analgesic effect of oral morphine in cancer patients.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6861871PubMed
6754208Clinical pharmacokinetics of pethidine: 1982.Clin Pharmacokinet1982https://conductscience.org/library/papers/6754208PubMed
6626417Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6626417PubMed
6362950First-pass elimination. Basic concepts and clinical consequences.Clin Pharmacokinet1984https://conductscience.org/library/papers/6362950PubMed
6352139Clinical pharmacokinetics of narcotic agonist-antagonist drugs.Clin Pharmacokinet1983https://conductscience.org/library/papers/6352139PubMed

See all 35 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/447033

GET https://conductscience.org/api/papers/v1/447033/cited_by?page=2